You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant Chemotherapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Shanghai (camrelizumab+chemo, Chemotherapy)

Recruiting
  • Gastric Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital
Aug 9, 2022

Rectal Cancer Trial in China (neoadjuvant chemo plus total mesorectal excision, total mesorectal excision)

Recruiting
  • Rectal Cancer
  • neoadjuvant chemotherapy plus total mesorectal excision
  • total mesorectal excision
  • Chongqing, Chongqing, China
  • +5 more
Aug 8, 2023

Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab Combined With Neoadjuvant Chemotherapy)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nimotuzumab Combined With Neoadjuvant Chemotherapy
  • (no location specified)
Jun 29, 2022

Locally Advanced Rectal Carcinoma Trial in Cairo (short course radiation therapy followed by 6 cycles of CAPOX then surgery)

Completed
  • Locally Advanced Rectal Carcinoma
  • short course radiation therapy followed by 6 cycles of CAPOX then surgery
  • Cairo, الجيزة, Egypt
    National Cancer Institute
Nov 11, 2022

Triple Negative Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (P10s-PADRE with MONTANIDE™ ISA 51 VG +

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Neoplasms
  • P10s-PADRE with MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Paclitaxel
  • Doxorubicin + Cyclophosphamide + Paclitaxel
  • Fayetteville, Arkansas
  • +1 more
Aug 18, 2022

Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple

Recruiting
  • Triple Negative Breast Cancer
    • New Haven, Connecticut
    • +2 more
    Jan 4, 2023

    Breast Cancer Trial in Boston (Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort, Diffuse Optical

    Enrolling by invitation
    • Breast Cancer
    • Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
    • Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort
    • Boston, Massachusetts
      Boston Medical Center
    Sep 20, 2022

    Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Jul 18, 2022

      Breast Cancer Trial in Gothenburg (MagTrace only, MagTrace and Magseed)

      Recruiting
      • Breast Cancer
      • MagTrace only
      • MagTrace and Magseed
      • Gothenburg, Sweden
        Sahlgrenska University Hospital
      Nov 22, 2022

      Cervix Cancer, Cervical Cancer, Cancer of the Uterine Cervix Trial in Varanasi (Neoadjuvant chemo)

      Completed
      • Cervix Cancer
      • +2 more
      • Neoadjuvant chemotherapy
      • Varanasi, UP, India
        Banaras Hindu University
      May 19, 2022

      Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +

      Completed
      • Breast Cancer
      • Breast Neoplasms
      • Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
      • Fayetteville, Arkansas
      • +1 more
      Jan 26, 2023

      Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus

      Not yet recruiting
      • Advanced Gastric Carcinoma
      • PDO group
      • Traditional group
      • Shanghai, Sahnghai, China
        Shanghai Ruijin Hospttal
      Apr 22, 2022

      Venous Thromboembolism, Ovarian Cancer Trial in Sarasota, Durham (Aspirin)

      Completed
      Has Results
      • Venous Thromboembolism
      • Ovarian Cancer
      • Sarasota, Florida
      • +1 more
      Sep 6, 2022

      Using Diffuse Optical Spectroscopic Imaging

      Withdrawn
      • Breast Cancer
      • Diffuse Optical Spectroscopy Imaging
      • Irvine, California
        Beckman Laser Institute
      Oct 28, 2022

      Retroperitoneal Sarcoma Trial in China (Doxorubicin+Ifosfamide+Anlotinib(AI+A), Radical Surgery)

      Enrolling by invitation
      • Retroperitoneal Sarcoma
      • Beijing, Beijing, China
      • +5 more
      May 11, 2023

      Breast Cancer, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy Trial in Fuzhou (carbon dye)

      Recruiting
      • Breast Cancer
      • +2 more
      • carbon dye
      • Fuzhou, Fujian, China
        Study Officials
      Aug 22, 2022

      Breast Tumors Trial in Quebec City (Angiomammography)

      Recruiting
      • Breast Neoplasms
      • Angiomammography
      • Quebec City, Quebec, Canada
        St-Sacrement Hospital
      Jun 10, 2022

      Breast Cancer Trial (Utidelone Injection in combination with AC, Docetaxel Injection in combination with AC)

      Not yet recruiting
      • Breast Cancer
      • Utidelone Injection in combination with AC
      • Docetaxel Injection in combination with AC
      • (no location specified)
      Jan 10, 2023

      Colorectal Cancer Trial (TACE protocol, Neoadjuvant Chemotherapy)

      Not yet recruiting
      • Colorectal Cancer
      • TACE protocol
      • Neoadjuvant Chemotherapy
      • (no location specified)
      Apr 15, 2022

      Breast Tumor, Chemo Effect Trial in Hong Kong (Magnetic seed localization)

      Recruiting
      • Breast Neoplasm
      • Chemotherapy Effect
      • Magnetic seed localization
      • Hong Kong, Hong Kong
        University of Hong Kong
      Jun 16, 2022

      Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Aug 23, 2022

      Disorder in Complete Remission in Response to Treatment Trial in Wuhan (Sintilimal Injection)

      Recruiting
      • Disorder in Complete Remission in Response to Treatment
      • Sintilimal Injection
      • Wuhan, Hubei, China
        Renmin Hospital of Wuhan University
      Sep 28, 2022

      Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

      Recruiting
      • Luminal B/HER2-negative Breast Cancer
      • Dalpiciclib combined with aromatase inhibitors
      • anthracycline-cyclophosphamide followed by taxane
      • Hangzhou, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Nov 30, 2022

      Ovarian Cancer Trial in Rome (Tumor and blood sample)

      Recruiting
      • Ovarian Cancer
      • Tumor and blood sample
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Jul 18, 2023

      Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Sun yat-sen University Cancer Center
      Oct 25, 2022